Related Experiment Video
Updated: Feb 6, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
Transgene-Free Direct Osteogenic Reprogramming Using Cell-Permeable Octamer-Binding Transcription Factor
Manho Kim1, Jaeyoung Lee1, Wijin Kim1
1Department of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea.
This study developed a novel protein-based method to convert fibroblasts into bone-forming osteoblasts using two transcription factors. This innovative approach shows promise for safer and more effective bone regenerative therapies.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Cell Biology
Background:
- Bone disorders like osteoporosis present significant clinical challenges.
- Current therapies face limitations due to scarce osteogenic cell sources and treatment complications.
Purpose of the Study:
- To develop a novel protein-based direct reprogramming platform for generating functional osteoblasts.
- To overcome limitations of existing cell sources and therapies for bone regeneration.
Main Methods:
- Utilized a protein-based system with two transcription factors, Oct4 and Cbfβ, fused to the cell-penetrating protein 30Kc19.
- Created recombinant proteins (Oct4-30Kc19 and Cbfβ-30Kc19) for enhanced cellular uptake and stability.
- Transplanted generated protein-induced osteoblasts (piOBs) into a murine calvarial defect model.
Main Results:
- Achieved high reprogramming efficiency of fibroblasts into osteoblasts with minimal cytotoxicity.
- Protein-induced osteoblasts (piOBs) displayed characteristic osteoblast morphology and gene expression.
- Transplantation of piOBs successfully induced significant new bone formation in vivo.
Conclusions:
- The novel 2-factor protein-based system offers a safer, scalable, and clinically feasible strategy for bone regenerative therapies.
- This method circumvents risks associated with viral vectors and genomic integration.
- Demonstrated therapeutic efficacy for bone diseases through in vivo bone formation.
More Related Videos
06:38High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
Published on: February 7, 2019
11:42Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
Published on: November 4, 2019
Related Concept Videos
Transcription Factors
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...